Annaı̈k Quémard - Concepedia

Author

Annaı̈k Quémard

Institut de Pharmacologie et de Biologie Structurale ORCID

Also Known As

A Quemard, A Quémard, A. Quemard, A. Quémard, Annaick Quemard, Annaiek Quemard, Annaik Quemard, Annaik Quémard, Annai¨k Quémard, Annaïk Quémard

Publications

4.9K

Citations

H-Index

Concepts

All Affiliations

Institut de Pharmacologie et de Biologie Structurale Centre National de la Recherche Scientifique Université Toulouse III - Paul Sabatier Université Fédérale de Toulouse Midi-Pyrénées Inserm

About

Annaı̈k Quémard is an author at Institut de Pharmacologie et de Biologie Structurale specializing in biochemistry, medicine, and biosynthesis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	19	21	1.3K
2	Medicine	18	18	1.2K
3	Natural Sciences	12	12	448
4	Engineering	6	6	276
5	Health Sciences	3	3	391

Annaı̈k Quémard

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
<i>inhA</i> , a Gene Encoding a Target for Isoniazid and Ethionamide in <i>Mycobacterium tuberculosis</i> Asesh Banerjee, Eugenie Dubnau, Annaı̈k Quémard, Science	1994	1.4K
Crystal Structure and Function of the Isoniazid Target of <i>Mycobacterium tuberculosis</i> Andréa Dessen, Annaı̈k Quémard, John S. Blanchard, Science	1995	428
Oxygenated mycolic acids are necessary for virulence of <i>Mycobacterium tuberculosis</i> in mice Eugenie Dubnau, John Chan, Catherine Raynaud, Molecular Microbiology	2000	314
InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II Hédia Marrakchi, Gilbert Lanéelle, Annaı̈k Quémard Microbiology BacteriologyInha InhibitorsMycolic Acid BiosynthesisDrug ResistanceBiosynthesis	2000	235
The missing piece of the type II fatty acid synthase system from <i>Mycobacterium tuberculosis</i> Emmanuelle Sacco, Adrian Suárez Covarrubias, Helen M. O’Hare, Proceedings of the National Academy of Sciences	2007	145
The Pks13/FadD32 Crosstalk for the Biosynthesis of Mycolic Acids in Mycobacterium tuberculosis Sabine Gavalda, Mathieu Léger, Benoı̂t van der Rest, Journal of Biological Chemistry Mycolic AcidsPulmonary TuberculosisBiosynthesisMedicineMycobacterium Tuberculosis	2009	128
MabA (FabG1), a Mycobacterium tuberculosis protein involved in the long-chain fatty acid elongation system FAS-II Hédia Marrakchi, Stéphanie Ducasse, Gilles Labesse, Microbiology	2002	123
The Polyketide Synthase Pks13 Catalyzes a Novel Mechanism of Lipid Transfer in Mycobacteria Sabine Gavalda, F. Bardou, Françoise Laval, Chemistry & Biology Novel MechanismBiosynthesisEngineeringBiochemistryBacteriology	2014	122
Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum Annaı̈k Quémard, C Lacave, Gilbert Lanéelle Antimicrobial Agents and Chemotherapy Secondary MetaboliteAntimicrobial ChemotherapyIsoniazid InhibitionDrug ResistanceBiosynthesis	1991	115
A Common Mechanism of Inhibition of the Mycobacterium tuberculosis Mycolic Acid Biosynthetic Pathway by Isoxyl and Thiacetazone Anna E. Grzegorzewicz, Jana Korduláková, Victoria Jones, Journal of Biological Chemistry	2012	99

Page 1